Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Global horizons of the WIN consortium

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.04.17
Views: 1962

Dr Vladimir Lazar - Chief Operating Officer, WIN Consortium

Dr Lazar speaks with ecancer at AACR 2017 about what the WIN symposium offers, how it compares to other oncology meetings taking place around the globe, and what innovations he foresees in cancer treatment.

He highlights the globally co-operative attitude of WIN consortium, reflected in the theme of this years conference, and introduces some key speakers.

Dr Lazar notes room for improvement in streamlining early diagnosis and delivering the latest therapies to clinics globally, and considers the future indications of combination therapies.

For more about the WIN consortium click here, or watch interviews from last year's symposium here.

Related videos

follow us


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation